Sofina
VC Fund
Brussels, Belgium
Sofina is an investment company that provides minority investments, private funds, guidance, market knowledge, networking, and investment services. They invests both directly and through Private Equity funds. They provide patient capital and advice to growing companies led by entrepreneurs and families and to support them as a long-term partnerwith other investors.
- Total investments:
- 116
- Last investment:
- Lead investor:
- 41%
Last updated:
For AI agents: llms.txt
Industries Sofina invests in
Stages Sofina invests in
Countries Sofina invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Benjamin Sabatier
|
|||
Harold Boël
|
|||
Maxence Tombeur
|
|||
Philippe Nyssen
|
|||
Stephanie Delperdange
|
Investment Focus
Industry
- E-Commerce 18 (16%)
- Health Care 10 (9%)
- Internet 9 (8%)
- Retail 7 (6%)
- Manufacturing 7 (6%)
Stage
- Series C 23 (20%)
- Series D 16 (14%)
- Series B 14 (12%)
- Series E 8 (7%)
- Private Equity 6 (5%)
Country
- India 18 (16%)
- United Kingdom 9 (8%)
- United States 8 (7%)
- China 6 (5%)
- Germany 6 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Benjamin Sabatier
Principal
|
Principal | Total investments: 2 | Find email | |
|
Harold Boël
Chief Executive Officer
|
Chief Executive Officer | Total investments: 9 | Find email | |
|
Maxence Tombeur
Head of Asia
|
Head of Asia | Total investments: 2 | Find email | |
|
Philippe Nyssen
VC & PE Investments
|
VC & PE Investments | Total investments: 0 | Find email | |
|
Stephanie Delperdange
Head of Luxembourg Office
|
Head of Luxembourg Office | Total investments: 0 | Find email | |
| See all 13 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Eye Security
|
Eye Security is a cybersecurity and insurtech startup combining no-nonsense cybersecurity measures with insurance for SMEs. It offers a high-quality, affordable all-in-one security product with active 24/7 protection and cyber insurance. The startup protects organizations from digital threats by making quality experts' knowledge andexperience available to entrepreneurs at all times, no matter what. Its mission is to make security accessible and affordable for every company. | $68.6M / Series C / Jun 29, 2026 | |
FirstClub
|
FirstClub's mission is to become a rapid commerce-first omnichannel retailer that uses offline experience stores to promote the quality of its items. FirstClub's goal is to create a platform that serves customers and offers brands a unique opportunity to connect with affluent homes. | $55M / Series B / Jun 04, 2026 | |
Primer
|
Primer is a financial technology company that provides payment infrastructure designed to help businesses manage and optimize payment operations through a single platform. The company enables merchants to connect with multiple payment service providers, fraud prevention tools, digital wallets, and other commerce-related services without buildingseparate integrations for each one. Its platform includes tools for payment routing, transaction monitoring, reconciliation, and workflow automation, allowing businesses to manage different stages of the payment lifecycle in one system. Primer also supports international payment operations by helping companies handle multiple currencies, regional payment methods, and provider integrations across markets. The company works with businesses in industries such as retail, travel, fintech, marketplaces, and digital services to simplify the management of complex payment ecosystems. | $100M / Series C / May 20, 2026 | |
Extreme shell technology
|
Extreme shell technology helps in creation and development of exoskeleton equipment for consumers. It uses data to drive exoskeleton innovation. | $50M / Series B / May 18, 2026 | |
XBOW
|
XBOW operates autonomously, carrying out commands and analyzing the results to achieve higher-level objectives. | $120M / Series C / Mar 18, 2026 | |
Talkiatry
|
Talkiatry is a company that offers virtual, in-network psychiatry services. The platform allows for virtual visits, ensuring convenience while maintaining a high standard of psychiatric care. The company connects patients with a team of licensed psychiatrists who can provide evaluation, diagnosis, and personalized treatment plans, includingmedication management if needed. Talkiatry specializes in treating a range of mental health conditions, such as anxiety, depression, ADHD, and substance use disorders, and aims to make high-quality psychiatric care accessible and convenient for patients. | $210M / Series D / Feb 12, 2026 | |
The Whole Truth
|
The Whole Truth produces plant-based food products aimed at providing snacks and meals made from natural ingredients. The company develops protein bars, nut butters, spreads, and other snack items with a focus on simple, recognizable ingredients without added sugars or artificial additives. Its product range targets consumers seeking convenient,plant-derived options for nutrition and snacking. The Whole Truth emphasizes ingredient transparency, detailing contents on packaging and in product information. The company manages product development, sourcing, and distribution to deliver consistent offerings to retail and direct-to-consumer channels. | $51M / Series D / Feb 04, 2026 | |
|
The Whole Truth
|
The Whole Truth produces plant-based food products aimed at providing snacks and meals made from natural ingredients. The company develops protein bars, nut butters, spreads, and other snack items with a focus on simple, recognizable ingredients without added sugars or artificial additives. Its product range targets consumers seeking convenient,plant-derived options for nutrition and snacking. The Whole Truth emphasizes ingredient transparency, detailing contents on packaging and in product information. The company manages product development, sourcing, and distribution to deliver consistent offerings to retail and direct-to-consumer channels. | Secondary Market / Feb 04, 2026 | |
Oviva
|
Oviva is digitizing the treatment of type 2 diabetes and obesity through a unique behavior change platform.They have developed unique, personalised behaviour change programmes that combine smartphone app and learning portals to support dietitian-led behaviour change for conditions such as type 2 diabetes and complex obesity. Their approach allowspatients to achieve a better health outcome without having to attend clinic appointments, whilst saving health systems significant sums by preventing the development of complications related to these health conditions.Oviva was founded in 2013 and is based in Altendorf (Switzerland) with offices in Zurich (Switzerland), London (United Kingdom), and Berlin (Germany). | $233.7M / Series D / Jan 22, 2026 | |
|
Oviva
|
Oviva is digitizing the treatment of type 2 diabetes and obesity through a unique behavior change platform.They have developed unique, personalised behaviour change programmes that combine smartphone app and learning portals to support dietitian-led behaviour change for conditions such as type 2 diabetes and complex obesity. Their approach allowspatients to achieve a better health outcome without having to attend clinic appointments, whilst saving health systems significant sums by preventing the development of complications related to these health conditions.Oviva was founded in 2013 and is based in Altendorf (Switzerland) with offices in Zurich (Switzerland), London (United Kingdom), and Berlin (Germany). | Secondary Market / Jan 22, 2026 | |
| See all 116 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Sofina invest in?
Sofina invests primarily in E-Commerce, Health Care and Internet startups, most often at Series C and Series D stage. Most of the 116 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Sofina?
Public channels for Sofina include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Sofina?
The team at Sofina includes Benjamin Sabatier (Principal), Harold Boël (Chief Executive Officer) and Maxence Tombeur (Head of Asia), among 13 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
